AKTS Aktis Oncology pre-market +8.54% at $21.98 03 Feb 2026: Watch 50-day

Aktis Oncology (AKTS) is trading higher in the pre-market after an oversold bounce lifted the share price 8.54% to $21.98 on 03 Feb 2026. AKTS stock saw 163,423 shares change hands versus an average of 527,480, signaling measured buying interest in the United States market on NASDAQ. Traders are watching the 50-day average $20.87 for confirmation of follow-through. This piece outlines technical triggers, valuation metrics, analyst context and a short-term trade plan for an oversold-bounce setup using Meyka AI’s market analysis platform.